ECSP15026152A - NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS - Google Patents

NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS

Info

Publication number
ECSP15026152A
ECSP15026152A ECIEPI201526152A ECSP15026152A ECSP15026152A EC SP15026152 A ECSP15026152 A EC SP15026152A EC IEPI201526152 A ECIEPI201526152 A EC IEPI201526152A EC SP15026152 A ECSP15026152 A EC SP15026152A EC SP15026152 A ECSP15026152 A EC SP15026152A
Authority
EC
Ecuador
Prior art keywords
muscarinic
activity
quinuclidinyl
antagonists
adrenergic agonists
Prior art date
Application number
ECIEPI201526152A
Other languages
Spanish (es)
Inventor
Moruno Ines Carranco
Pou Silvia Fonquerna
Duran Carlos Puig
Feu Laia Sole
Bosch Jose Aiguade
Original Assignee
Frigocon Ind De Frio E Congelacao S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frigocon Ind De Frio E Congelacao S A filed Critical Frigocon Ind De Frio E Congelacao S A
Publication of ECSP15026152A publication Critical patent/ECSP15026152A/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a nuevos compuestos que tienen doble actividad agonista Beta2 adrenérgica y antagonista muscarínica M3, a composiciones farmacéuticas que los contienen, al procedimiento para su preparación y a su uso en terapias de la vías respiratorias.The present invention relates to new compounds that have double beta2 adrenergic agonist and muscarinic M3 antagonist activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory tract therapies.

ECIEPI201526152A 2012-12-18 2015-06-18 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS ECSP15026152A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382513 2012-12-18
US201361750959P 2013-01-10 2013-01-10

Publications (1)

Publication Number Publication Date
ECSP15026152A true ECSP15026152A (en) 2016-01-29

Family

ID=73013111

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201526152A ECSP15026152A (en) 2012-12-18 2015-06-18 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS

Country Status (1)

Country Link
EC (1) ECSP15026152A (en)

Similar Documents

Publication Publication Date Title
CR20140182A (en) NEW CYCLOHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC B2 AGONISTS AND AS M3 MUSCARINIC ANTAGONISTS
ECSP14013340A (en) NEW CYCLOHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC AGONISTS? 2 AND AS M3 MUSCARINIC ANTAGONISTS
ECSP12012213A (en) NEW CYCLOHEXYLAMINE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC AGONISTS? 2 AND AS M3 MUSCARINIC ANTAGONISTS
UY35199A (en) New cyclohexyl and quinuclidinyl carbamate derivatives that have activity as beta2 adrenergic agonists and as M3 muscarinic antagonists
CR20150322A (en) NEW CARBAMATE DERIVATIVES OF CYCLHEXYL AND QUINUCLIDINYL THAT HAVE ACTIVITY AS B2 ADRENERGIC AGONISTS AND AS M3 MUSCARINIC ANTAGONISTS
CL2013001677A1 (en) Compounds derived from azabicyclo [3.2.1] octane; x fernesoid receptor agonist (fxr); process to prepare the compounds; intermediate compound; pharmaceutical composition and pharmaceutical combination that comprise a compound; and use of the compounds in the preparation of medicaments for the treatment of dyslipidemia.
CO7400870A2 (en) Quinuclidine derivative compounds with muscarinic receptor antagonist activity and beta2 adrenergic receptor agonist activity
GT201500094A (en) PIRROLOTRIAZINONA DERIVATIVES AS PI3K INHIBITORS
UY36329A (en) NEW BICYCLE DERIVATIVES THAT HAVE ACTIVITY AS ADRENERGIC AGENISTS ß2 AND AS M3 MUSCARINIC ANTAGONISTS
CR20150114A (en) COVERED PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
BR112015012746A2 (en) compounds having muscarinic receptor antagonist and beta2-adrenergic receptor agonist activity
DOP2013000307A (en) TRPV4 ANTAGONISTS
UY32734A (en) 1-PHOSPHATE RECEPTOR AGONIST COMPOUNDS
UY35708A (en) NEW COMPOUNDS AS ANTAGONISTS OF THE LISOPHOSPHYTIDIC ACID RECEPTOR
BR112013025682A2 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, COMBINATION AND DEVICE
UY34080A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES FEXOFENADINE AND PREPARATION METHODS
ECSP15026152A (en) NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES WHICH HAVE ACTIVITY AS BETA2 ADRENERGIC AGONISTS AND AS MUSCARINIC M3 ANTAGONISTS
DOP2015000049A (en) COVERED PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
UA112586C2 (en) BENZIMIDAZOLPROLINE DERIVATIVES
TN2013000429A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
BR112013017405A2 (en) non-competitive nicotinic receptor antagonists